ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

No Link Between Pneumonitis, Taxanes, And Radiation

November 26, 2004

Regulatory Approvals: Gardasil 9 approved, which covers five additional HPV types

December 12, 2014

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

NIC Grants Appeals Process Explained

April 19, 1985

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010